IL-6 deficiency leads to reduced metallothionein-I+II expression and increased oxidative stress in the brain stem after 6-aminonicotinamide treatment
about
Metallothionein mediates leukocyte chemotaxis.Neuroprotection by interleukin-6 is mediated by signal transducer and activator of transcription 3 and antioxidative signaling in ischemic stroke.Toll-like receptor-3 activation increases the vulnerability of the neonatal brain to hypoxia-ischemia.Prostaglandin E₂ is critical for the development of niacin-deficiency-induced photosensitivity via ROS productionHepatic expression of metallothionein I/II, glycoprotein 96, IL-6, and TGF- β in rat strains with different susceptibilities to experimental autoimmune encephalomyelitis.Metallothioneins and brain injury: What transgenic mice tell us.Metallothionein 1+2 protect the CNS during neuroglial degeneration induced by 6-aminonicotinamide.Increased vulnerability of dopaminergic neurons in MPTP-lesioned interleukin-6 deficient mice.Matrix metalloproteinases during and outside of migraine attacks without aura.Interleukin-6 promotes sprouting and functional recovery in lesioned organotypic hippocampal slice cultures.Effects of zinc on the induction of metallothionein isoforms in hippocampus in stress rats.RETRACTED: Metallothionein I+II expression and their role in experimental autoimmune encephalomyelitis
P2860
Q24815126-C4647DA6-B7E1-4204-843B-48AD9B63F0CAQ36091421-97BCF63A-D19B-48EC-89D4-37E86759CCCEQ37020230-5A0F62A6-3F2F-4982-8037-739365F5780CQ37232919-64284CCD-D303-41BC-8DFE-38B7497810BEQ41875308-DFAACC62-0C7C-477B-B0DC-BB05C99F4D4BQ41984348-BEE3B22C-A30A-43DA-9D2A-D1CAC2D76671Q42163275-6464E232-F05D-4B11-8DA7-97727C39395BQ44163162-FAA25588-23BC-4A77-8FD1-7621375F0187Q45082883-6FE1A052-E3C2-4141-ABA6-86846BEBFF21Q48348480-502E11C0-CB71-4935-B777-34BB43455371Q48405249-3A9C0361-1BC4-40E5-8AE1-9F7C08F41807Q56240158-06E2D413-BB5B-4A23-A8C9-BF12CFDB6A3D
P2860
IL-6 deficiency leads to reduced metallothionein-I+II expression and increased oxidative stress in the brain stem after 6-aminonicotinamide treatment
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
IL-6 deficiency leads to reduc ...... 6-aminonicotinamide treatment
@ast
IL-6 deficiency leads to reduc ...... 6-aminonicotinamide treatment
@en
IL-6 deficiency leads to reduc ...... 6-aminonicotinamide treatment
@nl
type
label
IL-6 deficiency leads to reduc ...... 6-aminonicotinamide treatment
@ast
IL-6 deficiency leads to reduc ...... 6-aminonicotinamide treatment
@en
IL-6 deficiency leads to reduc ...... 6-aminonicotinamide treatment
@nl
prefLabel
IL-6 deficiency leads to reduc ...... 6-aminonicotinamide treatment
@ast
IL-6 deficiency leads to reduc ...... 6-aminonicotinamide treatment
@en
IL-6 deficiency leads to reduc ...... 6-aminonicotinamide treatment
@nl
P356
P1476
IL-6 deficiency leads to reduc ...... 6-aminonicotinamide treatment
@en
P356
10.1006/EXNR.2000.7383
P407
P577
2000-05-01T00:00:00Z